Research graph
References from Development and Analytical Validation of a Smartphone‐Based Quantitative Lateral Flow Immunoassay for Serum Cystatin‐C. Local targets link to admitted publications; unresolved targets remain external evidence.
Cystatin C Versus Creatinine in Determining Risk Based on Kidney Function
10.1056/nejmoa1214234 · 2013 · External reference
Cystatin C: An Improved Estimator of Glomerular Filtration Rate?
10.1093/clinchem/48.5.699 · 2002 · External reference
Update on Cystatin C: Incorporation Into Clinical Practice
10.1053/j.ajkd.2013.03.027 · 2013 · External reference
Discordant Results Between Creatinine‐ and Cystatin C‐Based Equations for Estimating Glomerular Filtration Rate
10.1016/j.ekir.2025.01.030 · 2025 · External reference
Performance and Determinants of Serum Creatinine and Cystatin C‐Based GFR Estimating Equations in South Asians
10.1016/j.ekir.2021.01.005 · 2021 · External reference
Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons Without Chronic Kidney Disease
10.7326/0003-4819-145-4-200608150-00003 · 2006 · External reference
Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure
10.1161/circulationaha.106.644286 · 2007 · External reference
Plasma Concentrations of Cystatin C and Risk for Secondary Cardiovascular Events
10.1373/clinchem.2004.041889 · 2005 · External reference
Association of Plasma Cystatin C With All‐Cause and Cause‐Specific Mortality: A Prospective Cohort Study
10.1038/s41598-022-24722-4 · 2022 · External reference
Serum Cystatin C Is Superior to Serum Creatinine as a Marker of Kidney Function: A Meta‐Analysis
10.1053/ajkd.2002.34487 · 2002 · External reference
Biochemistry and Clinical Role of Human Cystatin C
10.1080/10408360490504934 · 2004 · External reference
Cystatin C Standardization Decreases Assay Variation and Improves Assessment of Glomerular Filtration Rate
10.1016/j.cca.2016.03.002 · 2016 · External reference
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in Children and Adults: A Commentary From the European Renal Best Practice (ERBP)
10.1093/ndt/gfae209 · 2025 · External reference
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
10.1016/j.kint.2021.05.021 · 2021 · External reference
Analytical Performances of PENIA and PETIA Urinary Cystatin C Determination Allow Tubular Injury Investigation
10.1177/0004563218816341 · 2019 · External reference
Analytical Performance of a Particle‐Enhanced Nephelometric Immunoassay for Serum Cystatin C Using Rate Analysis
10.1093/clinchem/47.8.1482 · 2001 · External reference
Measurement of Urinary Cystatin C With a Particle‐Enhanced Turbidimetric Immunoassay on Architect ci8200
10.1002/jcla.21531 · 2012 · External reference
Measurement of Cystatin C in Human Urine by Particle‐Enhanced Turbidimetric Immunoassay on an Automated Biochemistry Analyzer
10.1016/j.clinbiochem.2013.05.072 · 2013 · External reference
Measurement of Urinary Cystatin C by Particle‐Enhanced Turbidimetric Immunoassay (PETIA) on Automated Biochemistry Analyzer
2010 · External reference
A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub‐Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research
10.3233/jad-210741 · 2021 · External reference
Assessing the Salivary Levels of Cystatin C in Patients With Chronic Periodontitis Using Sandwich Enzyme‐Linked Immunosorbent Assay (ELISA)
10.1016/j.clinbiochem.2011.08.374 · 2011 · External reference
Performance of Colorimetric Lateral Flow Immunoassays for Renal Function Evaluation With Human Serum Cystatin C
10.3390/bios15070445 · 2025 · External reference
Lateral Flow Assays: Principles, Designs and Labels
10.1016/j.trac.2016.06.006 · 2016 · External reference
Designs, Formats and Applications of Lateral Flow Assay: A Literature Review
10.1016/j.jscs.2014.09.001 · 2015 · External reference
Point‐Of‐Care Diagnostic Tests for Low‐Resource Settings
10.1016/s2214-109x(15)70089-6 · 2015 · External reference
Nanomaterial‐Based Devices for Point‐Of‐Care Diagnostic Applications
10.1039/c7cs00837f · 2018 · External reference
Multiplexed Lateral Flow Biosensors: Technological Advances
10.1016/j.bios.2016.04.021 · 2016 · External reference
Smartphone Based Lateral Flow Immunoassay Quantifications
10.1016/j.jim.2024.113745 · 2024 · External reference
Development and Evaluation of a Quantitative Fluorescent Lateral Flow Immunoassay for Cystatin‐C, a Renal Dysfunction Biomarker
10.3390/s21093178 · 2021 · External reference
Lateral Flow Immunoassay Reader Technologies for Quantitative Point‐Of‐Care Testing
10.3390/s22197398 · 2022 · External reference
Turkevich Method for Gold Nanoparticle Synthesis Revisited
10.1021/jp061667w · 2006 · External reference
Unresolved reference
2005 · External reference
Unresolved reference
2003 · External reference
Unresolved reference
2012 · External reference
Unresolved reference
2005 · External reference
Unresolved reference
2002 · External reference
Europium (III) Chelate Nanoparticle‐Based Lateral Flow Immunoassay Strips for Rapid and Quantitative Detection of Cystatin C in Serum
10.1016/j.jchromb.2022.123133 · 2022 · External reference
The Quantitative Detection of Cystatin‐C in Patient Samples Using a Colorimetric Lateral Flow Immunoassay
10.3390/bios14010030 · 2024 · External reference
Development of Colorimetric Lateral Flow Assays With Gold Nanostructures for Cystatin C Detection
10.1016/j.snr.2022.100121 · 2022 · External reference
10.1021/acsnano.4c01824
10.1021/acsnano.4c01824 · External reference
10.1016/j.bioactmat.2025.11.043
10.1016/j.bioactmat.2025.11.043 · External reference
10.1002/advs.202502574
10.1002/advs.202502574 · External reference
